Biotechnology

Cytori Therapeutics will host a webcast to discuss their second quarter financial results on Friday, August 6, 2010 at 10:30 AM Eastern Time. Prior to the webcast at approximately 7:00 AM Eastern Time on August 6, Cytori will post a shareholder ...

Biodel Inc. will issue its third quarter fiscal year 2010 financial results on August 5, 2010. Following the release of the company's financial results, Biodel's senior management will host a conference call to discuss the results and provide an ...

Merck & Co., Inc. today announced financial results for the second quarter of 2010. The company reported non-GAAP earnings per share for the second quarter of $0.86, which excludes purchase accounting adjustments, merger-related expenses, ...

Covidien , a leading global provider of healthcare products, will present at the BMO Capital Markets 10th Annual Focus on Healthcare Conference in New York on Thursday, August 5, 2010. Jose Almeida, President, Medical Devices, will represent the ...

MicroStockProfit.com announces an investment report featuring Generex Biotechnology Corp. . The report includes financial, comparative and investment analyses, and recent company news that you need to know to make an educated investment decision.

BioScrip, Inc. announced 2010 second quarter revenue of $412.0 million, operating income of $13.5 million and net income of $3.1 million, or $0.06 per diluted share. Second quarter adjusted earnings per share was $0.07 per diluted share. Adjusted ...

Biocentric Energy Holdings, Inc. Dennis Fisher, Founder and Chairman of the Board today announced contracts for algae derived products are in the process of finalization:

As of July 30, 2010, the share capital in Diamyd Medical AB is 14,530,138.50 SEK. The total number of votes is 4,200,116 and the total number of shares is 29,060,277, divided among 1,437,876 shares of series A and 27,622,401 shares of series B .